| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 11,000 | $308.75 | $3,396,249.11 | -4.1% | +53.4% | - | |
| Aug 21, 2025 | BHC Bausch Health Companies Inc. | Lee Frank D. | Director | Sell | 15,912 | $7.66 | $121,885.92 | -17.7% | -19.3% | - | |
| Aug 21, 2025 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 100,000 | $90.36 | $9,036,007.96 | -9.8% | -11.9% | - | |
| Aug 21, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 146,000 | $0.30 | $43,240.80 | -1.4% | - | - | |
| Aug 20, 2025 | ANIP Ani Pharmaceuticals Inc | Pera Antonio R58 | Director | Sell | 5,421 | $89.73 | $486,426.33 | -15.3% | -10.5% | - | |
| Aug 20, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Boyer Andrew S | Executive Vice President | Sell | 279,244 | $9.38 | $2,619,308.72 | -64.7% | +23.0% | - | |
| Aug 20, 2025 | ETON Eton Pharmaceuticals, Inc. | Gruber James R. | Chief Financial Officer | Sell | 41,713 | $16.15 | $673,713.74 | -9.2% | +3.9% | - | |
| Aug 20, 2025 | LNTH Lantheus Holdings, Inc. | Patel Rajiv A | - | Sell | 3,406,000 | $56.14 | $191,213,690.00 | -24.8% | -4.7% | - | |
| Aug 20, 2025 | LNTH Lantheus Holdings, Inc. | Farallon Partners L L C/ca | - | Sell | 3,406,000 | $56.14 | $191,213,690.00 | -24.8% | -4.7% | - | |
| Aug 19, 2025 | LQDA Liquidia Corp | Horobin Joanna | Director | Sell | 5,000 | $27.17 | $135,850.00 | -12.9% | +4.8% | - | |
| Aug 18, 2025 | ANIP Ani Pharmaceuticals Inc | Leonard Matthew J | Director | Sell | 6,937 | $88.17 | $611,635.29 | -42.5% | -8.6% | - | |
| Aug 18, 2025 | PRGO Perrigo Co Plc | Parker Geoffrey M.46 | Director | Buy | 4,375 | $22.97 | $100,497.25 | +15.1% | -41.1% | - | |
| Aug 18, 2025 | COLL Collegium Pharmaceutical, Inc | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 16,389 | $38.21 | $626,171.25 | -13.7% | +18.7% | - | |
| Aug 18, 2025 | CGC Canopy Growth Corp | Gedeon Christelle80 | See Remarks | Sell | 4,528 | $1.86 | $8,422.08 | -1.2% | -23.4% | - | |
| Aug 18, 2025 | PRGO Perrigo Co Plc | Bezerra Eduardo Guarita45 | EVP &Chief Financial Officer | Buy | 3,000 | $22.74 | $68,206.80 | +6.5% | -41.1% | - | |
| Aug 18, 2025 | HIMS Hims & Hers Health, Inc. | Dudum Andrew47 | Chief Executive Officer | Sell | 175,661 | $45.06 | $7,914,734.62 | -20.7% | -21.1% | - | |
| Aug 18, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Tessari Eben | Chief Operating Officer | Sell | 16,200 | $33.77 | $547,141.00 | -16.7% | +22.8% | - | |
| Aug 18, 2025 | ANIP Ani Pharmaceuticals Inc | Thoma Jeanne | Director | Sell | 21,540 | $89.15 | $1,920,369.65 | -25.9% | -8.6% | - | |
| Aug 18, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 227,000 | $0.30 | $69,205.60 | -2.1% | - | - | |
| Aug 15, 2025 | ANIP Ani Pharmaceuticals Inc | Walsh Patrick D52 | Director | Sell | 9,000 | $89.05 | $801,450.00 | -11.4% | -3.3% | - | |
| Aug 15, 2025 | COLL Collegium Pharmaceutical, Inc | Santini Gino | Director | Sell | 5,405 | $37.19 | $201,018.44 | -5.4% | +22.9% | - | |
| Aug 15, 2025 | LQDA Liquidia Corp | Kaseta Michael57 | CFO And COO | Sell | 20,000 | $26.18 | $523,674.00 | -5.3% | +3.8% | - | |
| Aug 15, 2025 | ANIP Ani Pharmaceuticals Inc | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $86.97 | $1,739,400.00 | -10.4% | -3.3% | - | |
| Aug 15, 2025 | EOLS Evolus, Inc. | Stewart Brady | Director | Buy | 30,000 | $6.82 | $204,486.00 | +51.2% | +9.5% | - | |
| Aug 15, 2025 | LLY Eli Lilly & Co | Montarce Lucas | EVP &CFO | Buy | 715 | $691.79 | $494,626.99 | +5.1% | +45.9% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.